153 related articles for article (PubMed ID: 22578515)
1. Pilot production of recombinant human clotting factor IX from transgenic sow milk.
Sun YL; Chang YS; Lin YS; Yen CH
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jun; 898():78-89. PubMed ID: 22578515
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human factor IX produced from transgenic porcine milk.
Lee MH; Lin YS; Tu CF; Yen CH
Biomed Res Int; 2014; 2014():315375. PubMed ID: 24955355
[TBL] [Abstract][Full Text] [Related]
3. Stable and high-level production of recombinant Factor IX in human hepatic cell line.
de Castilho Fernandes A; Fontes A; Gonsales N; Swiech K; Picanco-Castro V; Faca S; Covas D
Biotechnol Appl Biochem; 2011; 58(4):243-9. PubMed ID: 21838798
[TBL] [Abstract][Full Text] [Related]
4. A novel method for separation of caseins from milk by phosphates precipitation.
Yen CH; Lin YS; Tu CF
Prep Biochem Biotechnol; 2015; 45(1):18-32. PubMed ID: 24372141
[TBL] [Abstract][Full Text] [Related]
5. Inactivation and clearance of viruses during the manufacture of high purity factor IX.
Johnston A; Macgregor A; Borovec S; Hattarki M; Stuckly K; Anderson D; Goss NH; Oates A; Uren E
Biologicals; 2000 Sep; 28(3):129-36. PubMed ID: 10964439
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution and pharmacokinetics of transgenic pig-produced recombinant human factor IX (rhFIX) in rats.
Chang CH; Chou TK; Yang CY; Chang TJ; Wu YH; Lee TW
In Vivo; 2008; 22(6):693-7. PubMed ID: 19180993
[TBL] [Abstract][Full Text] [Related]
7. Purification of recombinant DNA-derived factor IX produced in transgenic pig milk and fractionation of active and inactive subpopulations.
Lindsay M; Gil GC; Cadiz A; Velander WH; Zhang C; Van Cott KE
J Chromatogr A; 2004 Feb; 1026(1-2):149-57. PubMed ID: 14763741
[TBL] [Abstract][Full Text] [Related]
8. A galactopoiesis accordant yield of functional recombinant human factor IX from homozygous transgenic pigs requires a large amount of vitamin K supplementation.
Yen CH; Yang TS; Lin YS; Lee MH; Yu KC; Huang CL; Hsieh HH; Tu CF
Transgenic Res; 2016 Aug; 25(4):545-51. PubMed ID: 27160182
[TBL] [Abstract][Full Text] [Related]
9. [Contamination mechanism and regeneration strategies of chromatographic resin in separation process for expression product from mammary gland bioreactor].
Sun X; Zhang Y; Li Y; Luo J; Qin P; Su Z
Sheng Wu Gong Cheng Xue Bao; 2011 Nov; 27(11):1645-54. PubMed ID: 22393720
[TBL] [Abstract][Full Text] [Related]
10. Efficient separation of homologous alpha-lactalbumin from transgenic bovine milk using optimized hydrophobic interaction chromatography.
Zhang Y; Luo J; Bi J; Wang J; Sun L; Liu Y; Zhang G; Ma G; Su Z
J Chromatogr A; 2010 Jun; 1217(23):3668-73. PubMed ID: 20416878
[TBL] [Abstract][Full Text] [Related]
11. On-line casein micelle disruption for downstream purification of recombinant human myelin basic protein produced in the milk of transgenic cows.
Al-Ghobashy MA; Williams MA; Brophy B; Laible G; Harding DR
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jun; 877(16-17):1667-77. PubMed ID: 19419911
[TBL] [Abstract][Full Text] [Related]
12. The manufacturing process for recombinant factor IX.
Harrison S; Adamson S; Bonam D; Brodeur S; Charlebois T; Clancy B; Costigan R; Drapeau D; Hamilton M; Hanley K; Kelley B; Knight A; Leonard M; McCarthy M; Oakes P; Sterl K; Switzer M; Walsh R; Foster W
Semin Hematol; 1998 Apr; 35(2 Suppl 2):4-10. PubMed ID: 9565160
[TBL] [Abstract][Full Text] [Related]
13. Large-scale preparation of thrombin from human plasma.
Aizawa P; Winge S; Karlsson G
Thromb Res; 2008; 122(4):560-7. PubMed ID: 18329699
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of recombinant human factor IX: pharmacokinetic studies in the rat and the dog.
Keith JC; Ferranti TJ; Misra B; Frederick T; Rup B; McCarthy K; Faulkner R; Bush L; Schaub RG
Thromb Haemost; 1995 Jan; 73(1):101-5. PubMed ID: 7740479
[TBL] [Abstract][Full Text] [Related]
15. Anion-exchange purification of recombinant factor IX from cell culture supernatant using different chromatography supports.
Ribeiro DA; Passos DF; Ferraz HC; Castilho LR
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 938():111-8. PubMed ID: 24076525
[TBL] [Abstract][Full Text] [Related]
16. Inactivation strategy for pseudorabies virus in milk for production of biopharmaceuticals.
Chang JT; Chou YC; Lin MS; Wang SR
Jpn J Vet Res; 2010 Nov; 58(3-4):179-83. PubMed ID: 21180258
[TBL] [Abstract][Full Text] [Related]
17. Transgenic pigs as bioreactors: a comparison of gamma-carboxylation of glutamic acid in recombinant human protein C and factor IX by the mammary gland.
Van Cott KE; Butler SP; Russell CG; Subramanian A; Lubon H; Gwazdauskas FC; Knight J; Drohan WN; Velander WH
Genet Anal; 1999 Nov; 15(3-5):155-60. PubMed ID: 10596756
[TBL] [Abstract][Full Text] [Related]
18. Approaches for recombinant human factor IX production in serum-free suspension cultures.
do Amaral RL; de Sousa Bomfim A; de Abreu-Neto MS; Picanço-Castro V; de Sousa Russo EM; Covas DT; Swiech K
Biotechnol Lett; 2016 Mar; 38(3):385-94. PubMed ID: 26564408
[TBL] [Abstract][Full Text] [Related]
19. Expression of functional recombinant human factor IX in milk of mice.
Lisauskas SF; Cunha NB; Vianna GR; Mendes EA; Ramos GL; Maranhão AQ; Brígido MM; Almeida JO; Baptista HA; Motta FL; Pesquero JB; Aragão FJ; Rech EL
Biotechnol Lett; 2008 Dec; 30(12):2063-9. PubMed ID: 18688573
[TBL] [Abstract][Full Text] [Related]
20. Improved expression of recombinant human factor IX by co-expression of GGCX, VKOR and furin.
Liu J; Jonebring A; Hagström J; Nyström AC; Lövgren A
Protein J; 2014 Apr; 33(2):174-83. PubMed ID: 24567122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
